Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Front Oncol ; 13: 1142886, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-36910659

RESUMO

Background: EMT has been proposed to be a crucial early event in cancer metastasis. EMT is rigidly regulated by the action of several EMT-core transcription factors, particularly ZEB1. We previously revealed an unusual role of ZEB1 in the S100A8/A9-mediated metastasis in breast cancer cells that expressed ZEB1 at a significant level and showed that the ZEB1 was activated on the MCAM-downstream pathway upon S100A8/A9 binding. ZEB1 is well known to require Zn2+ for its activation based on the presence of several Zn-finger motifs in the transcription factor. However, how Zn2+-binding works on the pleiotropic role of ZEB1 through cancer progression has not been fully elucidated. Methods: We established the engineered cells, MDA-MB-231 MutZEB1 (MDA-MutZEB1), that stably express MutZEB1 (ΔZn). The cells were then evaluated in vitro for their invasion activities. Finally, an RNA-Seq analysis was performed to compare the gene alteration profiles of the established cells comprehensively. Results: MDA-MutZEB1 showed a significant loss of the EMT, ultimately stalling the invasion. Inclusive analysis of the transcription changes after the expression of MutZEB1 (ΔZn) in MDA-MB-231 cells revealed the significant downregulation of LOX family genes, which are known to play a critical role in cancer metastasis. We found that LOXL1 and LOXL4 remarkably enhanced cancer invasiveness among the LOX family genes with altered expression. Conclusions: These findings indicate that ZEB1 potentiates Zn2+-mediated transcription of plural EMT-relevant factors, including LOXL1 and LOXL4, whose upregulation plays a critical role in the invasive dissemination of breast cancer cells.

2.
Gerodontology ; 33(3): 342-7, 2016 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-25393605

RESUMO

OBJECTIVES: Polyclonal anti-Candida chicken egg yolk antibodies (anti-IgY) were used to investigate the prevention of adherence of Candida species to denture base material in vitro. BACKGROUND: Candida is a potential virulence factor that can cause systemic infection and even death in immunocompromised individuals. Because long-term antifungal treatment may lead to the emergence of drug-resistant strains, it is necessary to develop novel preventive measures and treatments for candidiasis. MATERIALS AND METHODS: Three types of chicken egg yolk antibodies were used in this study: non-specific antibody (control IgY), Candida albicans-specific antibody (anti-C.a.IgY) and Candida glabrata-specific antibody (anti-C.g.IgY). A mixture of different dilutions of each antibody with a suspension of Candida species and denture base material was incubated for 3 h, and then the colony-forming units of Candida on the denture base material were counted. RESULTS: Compared with control IgY, anti-C.a.IgY and anti-C.g.IgY significantly inhibited the adherence of C. albicans, but anti-C.a.IgY tended to be more potent than anti-C.g.IgY. The adherence of C. glabrata was also inhibited significantly by anti-C.a.IgY and anti-C.g.IgY with almost equivalent potency, indicating that their actions against C. glabrata were comparable. CONCLUSIONS: This study revealed the inhibitory effects of anti-C.a.IgY and anti-C.g.IgY against the adherence of C. albicans and C. glabrata to denture base material. This finding indicates the possibility of a beneficial effect of IgYs for the prevention of denture stomatitis and candidiasis in clinical settings.


Assuntos
Anticorpos/metabolismo , Candida/metabolismo , Bases de Dentadura/microbiologia , Estomatite sob Prótese/prevenção & controle , Animais , Candidíase/prevenção & controle , Galinhas , Gema de Ovo , Humanos
3.
BMC Oral Health ; 14: 14, 2014 Feb 20.
Artigo em Inglês | MEDLINE | ID: mdl-24552136

RESUMO

BACKGROUND: The isolation frequency and susceptibility to antifungal agents of oral Candida isolates from patients with oral candidiasis (OC) were compared between studies conducted in 2006-2007 and 2012-2013. METHODS: A total158 strains was isolated from 112 patients who visited Kagoshima University Hospital for the treatment of OC during the 14-month period from February 2012 and March 2013, and evaluated on the isolation frequency of each Candida strain and the susceptibility against antifungal drugs as compared to those evaluated in 2006-2007. RESULTS: There was a higher frequency of xerostomia as a chief complaint and of autoimmune disease in the 2012-2013 study than in the 2006-2007 study. More than 95% of Candida isolates were C. albicans and C. glabrata. In addition, the proportion of the latter increased from 12.3% in the 2006-2007 study to 23.4% in the 2012-2013 study, while the proportion of the former decreased from 86.2% to 72.8%, respectively. C. albicans was isolated in almost all patients, while C. glabrata was only isolated concomitantly with C. albicans. Minimal inhibitory concentrations (MICs) were not significantly different between groups with a few exceptions. Candida isolates, of which MICs surpassed break points, apparently increased for miconazole and itraconazole against C. glabrata in the 2012-2013 study, but this was not statistically significant. As a result, more cases of autoimmune disease, a greater number of C. glabrata isolates, and higher resistance to azoles were seen in the 2012-2013 study than in the 2006-2007 study. CONCLUSION: These data indicate that with recent increases in C. glabrata infection, a causative fungus of OC, and in C. glabrata resistance to azoles, caution is needed in the selection of antifungal drugs for the treatment of OC.


Assuntos
Antifúngicos/uso terapêutico , Candida/isolamento & purificação , Candidíase Bucal/microbiologia , Farmacorresistência Fúngica , Adulto , Idoso , Idoso de 80 Anos ou mais , Anfotericina B/uso terapêutico , Doenças Autoimunes/microbiologia , Carga Bacteriana , Candida/classificação , Candida/efeitos dos fármacos , Candida albicans/efeitos dos fármacos , Candida albicans/isolamento & purificação , Candida glabrata/efeitos dos fármacos , Candida glabrata/isolamento & purificação , Candidíase Bucal/tratamento farmacológico , Coinfecção/microbiologia , Equinocandinas/uso terapêutico , Feminino , Fluconazol/uso terapêutico , Flucitosina/uso terapêutico , Humanos , Itraconazol/uso terapêutico , Japão , Lipopeptídeos/uso terapêutico , Masculino , Micafungina , Miconazol/uso terapêutico , Testes de Sensibilidade Microbiana , Pessoa de Meia-Idade , Xerostomia/microbiologia
4.
Bioresour Technol ; 101 Suppl 1: S97-S100, 2010 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-19369062

RESUMO

Series nickel catalysts Ni/MgO(x)/CaO(1-)(x) (x=0.3, 0.5, 0.7, Ni: 5 wt%) were prepared and tested in fixed-bed reactor for biomass tar steam reforming, toluene as tar destruction model compound. Different ratios of MgO and CaO were mixed to simulate dolomite as Ni support. Two preparation methods: solid mixing with (SMW) and without water (SM) were used, the preparation methods and concentration of MgO had an important influence on toluene conversion and products. Catalysts prepared by SM method exhibited higher performance on toluene conversion, resulted in higher H(2) yield, and also, higher CO(2) and lower CO selectivity with higher temperature. For the same preparation method, higher concentration of MgO resulted in higher toluene conversion, and also influence on CO, CO(2) selectivity, but no obvious influence on the H(2) yield. Catalysts were characterized by BET, X-ray diffraction (XRD), SEM.


Assuntos
Compostos de Cálcio/química , Gases/química , Óxido de Magnésio/química , Níquel/química , Óxidos/química , Vapor , Alcatrões/química , Biomassa , Catálise , Hidrogênio/química , Microscopia Eletrônica de Varredura , Difração de Raios X
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...